Healthcare Equipment and Supplies
Company Overview of BioCision, LLC
BioCision, LLC develops portable benchtop tools for temperature sensitive biomedical samples for basic and clinical research and diagnostics. It offers cell freezing containers microfuges, storage, portable ice-free cooling/freezing, cool and thermaltrays, ergotubes, accessories, and clinic products. The company’s products are used by researchers in bio-pharma, academic research, clinical research and diagnostics, hospital, government, industry, and medical devices customers. It offers products through distributors in the United States, Canada, Europe, Asia, the Middle East, Australia, and New Zealand; and online. The company was founded in 2007 and is based in Larkspur, California.
12 East Sir Francis Drake Boulevard
Larkspur, CA 94939
Founded in 2007
Key Executives for BioCision, LLC
Chief Executive Officer, President and Director
Vice President of Operations
President of Dark Horse Consulting
Chief Commercialization Officer
Compensation as of Fiscal Year 2015.
BioCision, LLC Key Developments
BioCision Announces FDA Master File Acceptance for ThawSTAR Automated Cell Thawing Instrument
Sep 9 15
BioCision, LLC announced that the United States Food and Drug Administration (FDA), Center for Devices and Radiological Health, accepted its Device Master File (MAF) submission for the ThawSTAR automated cell thawing system. Utilizing patent-pending STAR™ sensing technology, the ThawSTAR thawing instrument employs multiple detection mechanisms and algorithms to determine vial temperature, phase change initiation and thaw completion, customizing the thaw for each vial containing frozen cellular material. The system’s intuitive, hands-free operation eliminates the guesswork and subjectivity of determining the thawing end point, setting a new bar in thawing reproducibility and making it a necessary component in processes that rely on standardized procedures.
Cook Regentec Selects BioCision, LLC's Proprietary Coolcell Technology
Jul 28 15
BioCision, LLC announced that they have entered into an exclusive partnership with Cook Regentec to develop two custom CoolCell controlled-rate cell freezing systems for Cook's closed-system cell therapy CellSeal vials. Cook selected BioCision's proprietary CoolCell technology for its effectiveness in standardizing the freezing of cells and cellular therapies such as stem cells and tissue samples that can be used in a wide range of applications from diabetes research to organ transplants. The ease of implementation and use of CoolCell freezing systems, especially as compared to expensive controlled-rate freezers, will provide Cook's CellSeal vial customers a cost-effective, reliable solution for controlled -1 degree Celsius per minute cell freezing, the rate believed to be optimal to ensuring cells remain intact and experience minimal negative effects during the freezing process.
BioCision, LLC to Develop Customized ThawSTAR Automated Cell Thawing System for Celgene Cellular Therapeutics
Jun 1 15
BioCision, LLC announced that it will collaborate with Celgene Cellular Therapeutics (CCT) to accelerate the development of a cell thawing solution based on BioCision's proprietary ThawSTAR™ technology for the 6 mL injectable vial that CCT has chosen to store PDA-002, a cryopreserved, allogeneic cell therapy currently in clinical development to treat diabetic foot ulcers in patients with peripheral arterial disease. Conventional thawing methods, including swirling vials in warm water baths or rolling vials between hands can result in variable cell viabilities and can increase contamination concerns. BioCision’s ThawSTAR system utilizes a patent pending adaptive sensing technology that incorporates algorithms to deliver a consistent and reproducible thaw profile and endpoint to each vial, thus providing a standardized thawing process, eliminating variability that could have a detrimental effect on the safety and efficacy of the cell therapy, and providing a significant reduction in cell handling risk in a clinical setting. The new ThawSTAR automated cell thawing system that will be developed as a result of this collaboration is an expansion of BioCision’s technology platform and will be made available commercially. BioCision is also developing other vial formats to address the needs of the larger cell therapy market.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 22, 2014